nodes	percent_of_prediction	percent_of_DWPC	metapath
Cetrorelix—Local reaction—Vinorelbine—lung cancer	0.014	0.0339	CcSEcCtD
Cetrorelix—Redness—Paclitaxel—lung cancer	0.00774	0.0187	CcSEcCtD
Cetrorelix—Injection site reaction—Vinorelbine—lung cancer	0.00772	0.0187	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Topotecan—lung cancer	0.00681	0.0165	CcSEcCtD
Cetrorelix—Erythema—Pemetrexed—lung cancer	0.00661	0.016	CcSEcCtD
Cetrorelix—Redness—Docetaxel—lung cancer	0.00656	0.0159	CcSEcCtD
Cetrorelix—Injection site reaction—Gemcitabine—lung cancer	0.0062	0.015	CcSEcCtD
Cetrorelix—Contusion—Paclitaxel—lung cancer	0.00599	0.0145	CcSEcCtD
Cetrorelix—Cough—Gefitinib—lung cancer	0.00573	0.0139	CcSEcCtD
Cetrorelix—Anaphylactic shock—Pemetrexed—lung cancer	0.0054	0.013	CcSEcCtD
Cetrorelix—Injection site reaction—Paclitaxel—lung cancer	0.00519	0.0126	CcSEcCtD
Cetrorelix—Hypotension—Gefitinib—lung cancer	0.00501	0.0121	CcSEcCtD
Cetrorelix—Local reaction—Doxorubicin—lung cancer	0.00499	0.0121	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Irinotecan—lung cancer	0.00481	0.0116	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Gemcitabine—lung cancer	0.00468	0.0113	CcSEcCtD
Cetrorelix—Injection site reaction—Docetaxel—lung cancer	0.0044	0.0106	CcSEcCtD
Cetrorelix—Swelling—Etoposide—lung cancer	0.00439	0.0106	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Cisplatin—lung cancer	0.00436	0.0105	CcSEcCtD
Cetrorelix—Swelling—Paclitaxel—lung cancer	0.0043	0.0104	CcSEcCtD
Cetrorelix—Immune system disorder—Topotecan—lung cancer	0.00412	0.00996	CcSEcCtD
Cetrorelix—Redness—Doxorubicin—lung cancer	0.00409	0.0099	CcSEcCtD
Cetrorelix—Hypotension—Teniposide—lung cancer	0.00408	0.00987	CcSEcCtD
Cetrorelix—Hot flush—Paclitaxel—lung cancer	0.00405	0.0098	CcSEcCtD
Cetrorelix—Menopausal symptoms—Paclitaxel—lung cancer	0.00402	0.00972	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Etoposide—lung cancer	0.004	0.00966	CcSEcCtD
Cetrorelix—Hypersensitivity—Pemetrexed—lung cancer	0.00398	0.00961	CcSEcCtD
Cetrorelix—Hypersensitivity—Gefitinib—lung cancer	0.00395	0.00955	CcSEcCtD
Cetrorelix—Erythema—Erlotinib—lung cancer	0.00393	0.0095	CcSEcCtD
Cetrorelix—Pruritus—Pemetrexed—lung cancer	0.00382	0.00923	CcSEcCtD
Cetrorelix—Pruritus—Gefitinib—lung cancer	0.00379	0.00917	CcSEcCtD
Cetrorelix—Rash—Crizotinib—lung cancer	0.00372	0.009	CcSEcCtD
Cetrorelix—Dermatitis—Crizotinib—lung cancer	0.00372	0.00899	CcSEcCtD
Cetrorelix—Swelling—Docetaxel—lung cancer	0.00364	0.00881	CcSEcCtD
Cetrorelix—Immune system disorder—Vinorelbine—lung cancer	0.00352	0.00852	CcSEcCtD
Cetrorelix—Nausea—Crizotinib—lung cancer	0.00351	0.00848	CcSEcCtD
Cetrorelix—Cough—Topotecan—lung cancer	0.00346	0.00837	CcSEcCtD
Cetrorelix—Hot flush—Docetaxel—lung cancer	0.00344	0.00831	CcSEcCtD
Cetrorelix—Cough—Erlotinib—lung cancer	0.00343	0.00829	CcSEcCtD
Cetrorelix—Menopausal symptoms—Docetaxel—lung cancer	0.00341	0.00824	CcSEcCtD
Cetrorelix—Rash—Pemetrexed—lung cancer	0.0034	0.00823	CcSEcCtD
Cetrorelix—Dermatitis—Pemetrexed—lung cancer	0.0034	0.00822	CcSEcCtD
Cetrorelix—Erythema—Vinorelbine—lung cancer	0.0034	0.00821	CcSEcCtD
Cetrorelix—Rash—Gefitinib—lung cancer	0.00338	0.00817	CcSEcCtD
Cetrorelix—Dermatitis—Gefitinib—lung cancer	0.00338	0.00817	CcSEcCtD
Cetrorelix—Anaphylactic shock—Topotecan—lung cancer	0.00324	0.00783	CcSEcCtD
Cetrorelix—Hypersensitivity—Teniposide—lung cancer	0.00322	0.00779	CcSEcCtD
Cetrorelix—Nausea—Pemetrexed—lung cancer	0.00321	0.00775	CcSEcCtD
Cetrorelix—Nausea—Gefitinib—lung cancer	0.00319	0.0077	CcSEcCtD
Cetrorelix—Pruritus—Teniposide—lung cancer	0.00309	0.00748	CcSEcCtD
Cetrorelix—Cough—Vinorelbine—lung cancer	0.00296	0.00716	CcSEcCtD
Cetrorelix—Immune system disorder—Irinotecan—lung cancer	0.00291	0.00703	CcSEcCtD
Cetrorelix—Immune system disorder—Gemcitabine—lung cancer	0.00283	0.00684	CcSEcCtD
Cetrorelix—Anaphylactic shock—Vinorelbine—lung cancer	0.00277	0.0067	CcSEcCtD
Cetrorelix—Rash—Teniposide—lung cancer	0.00276	0.00666	CcSEcCtD
Cetrorelix—Dermatitis—Teniposide—lung cancer	0.00275	0.00666	CcSEcCtD
Cetrorelix—Injection site reaction—Doxorubicin—lung cancer	0.00275	0.00664	CcSEcCtD
Cetrorelix—Headache—Teniposide—lung cancer	0.00274	0.00662	CcSEcCtD
Cetrorelix—Erythema—Gemcitabine—lung cancer	0.00273	0.0066	CcSEcCtD
Cetrorelix—Immune system disorder—Cisplatin—lung cancer	0.00264	0.00638	CcSEcCtD
Cetrorelix—Nausea—Teniposide—lung cancer	0.0026	0.00628	CcSEcCtD
Cetrorelix—Hypotension—Vinorelbine—lung cancer	0.00259	0.00626	CcSEcCtD
Cetrorelix—Erythema—Cisplatin—lung cancer	0.00254	0.00615	CcSEcCtD
Cetrorelix—Hypersensitivity—Vinblastine—lung cancer	0.00246	0.00594	CcSEcCtD
Cetrorelix—Cough—Irinotecan—lung cancer	0.00244	0.00591	CcSEcCtD
Cetrorelix—Immune system disorder—Etoposide—lung cancer	0.00242	0.00584	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Methotrexate—lung cancer	0.00239	0.00579	CcSEcCtD
Cetrorelix—Hypersensitivity—Topotecan—lung cancer	0.00239	0.00577	CcSEcCtD
Cetrorelix—Cough—Gemcitabine—lung cancer	0.00238	0.00576	CcSEcCtD
Cetrorelix—Immune system disorder—Paclitaxel—lung cancer	0.00237	0.00573	CcSEcCtD
Cetrorelix—GNRHR—GPCR ligand binding—ANXA1—lung cancer	0.0023	0.00392	CbGpPWpGaD
Cetrorelix—Pruritus—Topotecan—lung cancer	0.00229	0.00554	CcSEcCtD
Cetrorelix—GNRHR—Signaling by GPCR—GIPR—lung cancer	0.00229	0.0039	CbGpPWpGaD
Cetrorelix—Anaphylactic shock—Irinotecan—lung cancer	0.00229	0.00553	CcSEcCtD
Cetrorelix—Erythema—Paclitaxel—lung cancer	0.00228	0.00552	CcSEcCtD
Cetrorelix—Pruritus—Erlotinib—lung cancer	0.00227	0.00548	CcSEcCtD
Cetrorelix—LHCGR—Signaling by GPCR—GNG11—lung cancer	0.00224	0.00382	CbGpPWpGaD
Cetrorelix—Anaphylactic shock—Gemcitabine—lung cancer	0.00223	0.00538	CcSEcCtD
Cetrorelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—AVP—lung cancer	0.00222	0.00379	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—ADCY1—lung cancer	0.00222	0.00378	CbGpPWpGaD
Cetrorelix—LHCGR—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	0.00221	0.00376	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR ligand binding—APP—lung cancer	0.00218	0.00371	CbGpPWpGaD
Cetrorelix—Hot flush—Doxorubicin—lung cancer	0.00214	0.00519	CcSEcCtD
Cetrorelix—GNRHR—GPCR downstream signaling—GRM8—lung cancer	0.00214	0.00365	CbGpPWpGaD
Cetrorelix—Hypotension—Irinotecan—lung cancer	0.00214	0.00516	CcSEcCtD
Cetrorelix—Menopausal symptoms—Doxorubicin—lung cancer	0.00213	0.00514	CcSEcCtD
Cetrorelix—Headache—Vinblastine—lung cancer	0.00209	0.00505	CcSEcCtD
Cetrorelix—Hypotension—Gemcitabine—lung cancer	0.00208	0.00503	CcSEcCtD
Cetrorelix—Anaphylactic shock—Cisplatin—lung cancer	0.00208	0.00502	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Doxorubicin—lung cancer	0.00207	0.00501	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—COL4A2—lung cancer	0.00207	0.00353	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—PTHLH—lung cancer	0.00206	0.00352	CbGpPWpGaD
Cetrorelix—Rash—Topotecan—lung cancer	0.00204	0.00494	CcSEcCtD
Cetrorelix—Hypersensitivity—Vinorelbine—lung cancer	0.00204	0.00494	CcSEcCtD
Cetrorelix—Dermatitis—Topotecan—lung cancer	0.00204	0.00493	CcSEcCtD
Cetrorelix—Cough—Etoposide—lung cancer	0.00203	0.00491	CcSEcCtD
Cetrorelix—Headache—Topotecan—lung cancer	0.00203	0.00491	CcSEcCtD
Cetrorelix—Rash—Erlotinib—lung cancer	0.00202	0.00489	CcSEcCtD
Cetrorelix—Dermatitis—Erlotinib—lung cancer	0.00202	0.00488	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—GIPR—lung cancer	0.00202	0.00344	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—ADCY1—lung cancer	0.00201	0.00344	CbGpPWpGaD
Cetrorelix—Immune system disorder—Docetaxel—lung cancer	0.00201	0.00486	CcSEcCtD
Cetrorelix—Headache—Erlotinib—lung cancer	0.00201	0.00485	CcSEcCtD
Cetrorelix—Cough—Paclitaxel—lung cancer	0.00199	0.00482	CcSEcCtD
Cetrorelix—Nausea—Vinblastine—lung cancer	0.00198	0.00479	CcSEcCtD
Cetrorelix—LHCGR—Signaling by GPCR—PPP2R1B—lung cancer	0.00196	0.00335	CbGpPWpGaD
Cetrorelix—Pruritus—Vinorelbine—lung cancer	0.00196	0.00474	CcSEcCtD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—lung cancer	0.00195	0.00332	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—GRM8—lung cancer	0.00195	0.00332	CbGpPWpGaD
Cetrorelix—Hypotension—Cisplatin—lung cancer	0.00194	0.00469	CcSEcCtD
Cetrorelix—LHCGR—GPCR downstream signaling—ANXA1—lung cancer	0.00194	0.00331	CbGpPWpGaD
Cetrorelix—Erythema—Docetaxel—lung cancer	0.00194	0.00468	CcSEcCtD
Cetrorelix—Nausea—Topotecan—lung cancer	0.00192	0.00465	CcSEcCtD
Cetrorelix—Nausea—Erlotinib—lung cancer	0.0019	0.0046	CcSEcCtD
Cetrorelix—Anaphylactic shock—Etoposide—lung cancer	0.0019	0.0046	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—SDC4—lung cancer	0.00188	0.00321	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—PTHLH—lung cancer	0.00187	0.00319	CbGpPWpGaD
Cetrorelix—Anaphylactic shock—Paclitaxel—lung cancer	0.00186	0.00451	CcSEcCtD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—lung cancer	0.00185	0.00316	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—DUSP3—lung cancer	0.00185	0.00315	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—APP—lung cancer	0.00184	0.00313	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—RHEB—lung cancer	0.00181	0.00309	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—AXL—lung cancer	0.00178	0.00304	CbGpPWpGaD
Cetrorelix—Hypotension—Etoposide—lung cancer	0.00178	0.0043	CcSEcCtD
Cetrorelix—GNRHR—GPCR downstream signaling—OXTR—lung cancer	0.00176	0.00301	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—GRP—lung cancer	0.00176	0.00301	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—ANXA1—lung cancer	0.00176	0.003	CbGpPWpGaD
Cetrorelix—Rash—Vinorelbine—lung cancer	0.00175	0.00422	CcSEcCtD
Cetrorelix—Dermatitis—Vinorelbine—lung cancer	0.00175	0.00422	CcSEcCtD
Cetrorelix—Hypotension—Paclitaxel—lung cancer	0.00174	0.00421	CcSEcCtD
Cetrorelix—Headache—Vinorelbine—lung cancer	0.00174	0.0042	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—GRM8—lung cancer	0.00172	0.00293	CbGpPWpGaD
Cetrorelix—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	0.00171	0.00291	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR ligand binding—AVP—lung cancer	0.00169	0.00289	CbGpPWpGaD
Cetrorelix—Cough—Docetaxel—lung cancer	0.00169	0.00408	CcSEcCtD
Cetrorelix—Hypersensitivity—Irinotecan—lung cancer	0.00168	0.00407	CcSEcCtD
Cetrorelix—LHCGR—GPCR ligand binding—POMC—lung cancer	0.00168	0.00287	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—APP—lung cancer	0.00167	0.00285	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—SKI—lung cancer	0.00166	0.00284	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—GNG11—lung cancer	0.00165	0.00282	CbGpPWpGaD
Cetrorelix—Nausea—Vinorelbine—lung cancer	0.00165	0.00398	CcSEcCtD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—lung cancer	0.00165	0.00281	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—GRP—lung cancer	0.0016	0.00273	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—OXTR—lung cancer	0.0016	0.00273	CbGpPWpGaD
Cetrorelix—Anaphylactic shock—Docetaxel—lung cancer	0.00158	0.00382	CcSEcCtD
Cetrorelix—Pruritus—Gemcitabine—lung cancer	0.00158	0.00381	CcSEcCtD
Cetrorelix—Hypersensitivity—Cisplatin—lung cancer	0.00153	0.0037	CcSEcCtD
Cetrorelix—GNRHR—Signaling by GPCR—GNG11—lung cancer	0.0015	0.00256	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—ADCY1—lung cancer	0.00148	0.00253	CbGpPWpGaD
Cetrorelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	0.00148	0.00252	CbGpPWpGaD
Cetrorelix—Hypotension—Docetaxel—lung cancer	0.00148	0.00357	CcSEcCtD
Cetrorelix—Immune system disorder—Methotrexate—lung cancer	0.00145	0.0035	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—PXN—lung cancer	0.00144	0.00246	CbGpPWpGaD
Cetrorelix—Rash—Irinotecan—lung cancer	0.00144	0.00348	CcSEcCtD
Cetrorelix—Dermatitis—Irinotecan—lung cancer	0.00144	0.00348	CcSEcCtD
Cetrorelix—Headache—Irinotecan—lung cancer	0.00143	0.00346	CcSEcCtD
Cetrorelix—LHCGR—GPCR downstream signaling—AVP—lung cancer	0.00143	0.00244	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—AKR1C1—lung cancer	0.00141	0.00241	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—GRP—lung cancer	0.00141	0.00241	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—OXTR—lung cancer	0.00141	0.00241	CbGpPWpGaD
Cetrorelix—Rash—Gemcitabine—lung cancer	0.0014	0.00339	CcSEcCtD
Cetrorelix—Dermatitis—Gemcitabine—lung cancer	0.0014	0.00339	CcSEcCtD
Cetrorelix—Hypersensitivity—Etoposide—lung cancer	0.0014	0.00339	CcSEcCtD
Cetrorelix—Erythema—Methotrexate—lung cancer	0.0014	0.00337	CcSEcCtD
Cetrorelix—Headache—Gemcitabine—lung cancer	0.00139	0.00337	CcSEcCtD
Cetrorelix—GNRHR—Signaling Pathways—COL4A2—lung cancer	0.00139	0.00237	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—PTHLH—lung cancer	0.00138	0.00235	CbGpPWpGaD
Cetrorelix—Hypersensitivity—Paclitaxel—lung cancer	0.00137	0.00332	CcSEcCtD
Cetrorelix—Nausea—Irinotecan—lung cancer	0.00136	0.00328	CcSEcCtD
Cetrorelix—GNRHR—Signaling Pathways—GIPR—lung cancer	0.00135	0.0023	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—ADCY1—lung cancer	0.00135	0.0023	CbGpPWpGaD
Cetrorelix—Pruritus—Etoposide—lung cancer	0.00135	0.00325	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—GNG11—lung cancer	0.00132	0.00226	CbGpPWpGaD
Cetrorelix—Nausea—Gemcitabine—lung cancer	0.00132	0.0032	CcSEcCtD
Cetrorelix—Pruritus—Paclitaxel—lung cancer	0.00132	0.00319	CcSEcCtD
Cetrorelix—GNRHR—Signaling by GPCR—PPP2R1B—lung cancer	0.00131	0.00224	CbGpPWpGaD
Cetrorelix—Rash—Cisplatin—lung cancer	0.00131	0.00316	CcSEcCtD
Cetrorelix—Dermatitis—Cisplatin—lung cancer	0.00131	0.00316	CcSEcCtD
Cetrorelix—LHCGR—GPCR ligand binding—CXCL8—lung cancer	0.0013	0.00222	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—AVP—lung cancer	0.0013	0.00221	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—ANXA1—lung cancer	0.0013	0.00221	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—SDC4—lung cancer	0.00126	0.00215	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—VEGFC—lung cancer	0.00126	0.00215	CbGpPWpGaD
Cetrorelix—Immune system disorder—Doxorubicin—lung cancer	0.00125	0.00303	CcSEcCtD
Cetrorelix—GNRHR—Signaling by GPCR—PTHLH—lung cancer	0.00125	0.00214	CbGpPWpGaD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—lung cancer	0.00124	0.00211	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—DUSP3—lung cancer	0.00124	0.00211	CbGpPWpGaD
Cetrorelix—Nausea—Cisplatin—lung cancer	0.00123	0.00298	CcSEcCtD
Cetrorelix—GNRHR—GPCR downstream signaling—APP—lung cancer	0.00123	0.0021	CbGpPWpGaD
Cetrorelix—Cough—Methotrexate—lung cancer	0.00122	0.00294	CcSEcCtD
Cetrorelix—GNRHR—Signaling Pathways—RHEB—lung cancer	0.00121	0.00207	CbGpPWpGaD
Cetrorelix—Erythema—Doxorubicin—lung cancer	0.00121	0.00292	CcSEcCtD
Cetrorelix—Rash—Etoposide—lung cancer	0.0012	0.0029	CcSEcCtD
Cetrorelix—Dermatitis—Etoposide—lung cancer	0.0012	0.0029	CcSEcCtD
Cetrorelix—Headache—Etoposide—lung cancer	0.00119	0.00288	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—ADCY1—lung cancer	0.00119	0.00203	CbGpPWpGaD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—lung cancer	0.00119	0.00202	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—ANXA1—lung cancer	0.00118	0.00201	CbGpPWpGaD
Cetrorelix—Rash—Paclitaxel—lung cancer	0.00118	0.00284	CcSEcCtD
Cetrorelix—Dermatitis—Paclitaxel—lung cancer	0.00117	0.00284	CcSEcCtD
Cetrorelix—Headache—Paclitaxel—lung cancer	0.00117	0.00282	CcSEcCtD
Cetrorelix—Hypersensitivity—Docetaxel—lung cancer	0.00116	0.00281	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—SMARCA4—lung cancer	0.00116	0.00198	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PPP2R1B—lung cancer	0.00116	0.00198	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—GRM8—lung cancer	0.00115	0.00196	CbGpPWpGaD
Cetrorelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	0.00114	0.00195	CbGpPWpGaD
Cetrorelix—Anaphylactic shock—Methotrexate—lung cancer	0.00114	0.00275	CcSEcCtD
Cetrorelix—Nausea—Etoposide—lung cancer	0.00113	0.00273	CcSEcCtD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—lung cancer	0.00113	0.00192	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR ligand binding—POMC—lung cancer	0.00113	0.00192	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—HSPB1—lung cancer	0.00112	0.00191	CbGpPWpGaD
Cetrorelix—Pruritus—Docetaxel—lung cancer	0.00112	0.0027	CcSEcCtD
Cetrorelix—GNRHR—Signaling by GPCR—APP—lung cancer	0.00112	0.00191	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—SKI—lung cancer	0.00111	0.0019	CbGpPWpGaD
Cetrorelix—Nausea—Paclitaxel—lung cancer	0.00111	0.00268	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—PTHLH—lung cancer	0.00111	0.00189	CbGpPWpGaD
Cetrorelix—GNRHR—G alpha (q) signalling events—PIK3CA—lung cancer	0.00109	0.00187	CbGpPWpGaD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—lung cancer	0.00107	0.00182	CbGpPWpGaD
Cetrorelix—Hypotension—Methotrexate—lung cancer	0.00106	0.00257	CcSEcCtD
Cetrorelix—Cough—Doxorubicin—lung cancer	0.00105	0.00255	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—ANXA1—lung cancer	0.00104	0.00177	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—FLT1—lung cancer	0.00101	0.00172	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—PIK3CG—lung cancer	0.000998	0.0017	CbGpPWpGaD
Cetrorelix—Rash—Docetaxel—lung cancer	0.000996	0.00241	CcSEcCtD
Cetrorelix—Dermatitis—Docetaxel—lung cancer	0.000995	0.00241	CcSEcCtD
Cetrorelix—Headache—Docetaxel—lung cancer	0.00099	0.00239	CcSEcCtD
Cetrorelix—Anaphylactic shock—Doxorubicin—lung cancer	0.000986	0.00238	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—NOTCH3—lung cancer	0.000986	0.00168	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—APP—lung cancer	0.000986	0.00168	CbGpPWpGaD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—lung cancer	0.000979	0.00167	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—FGF9—lung cancer	0.000978	0.00167	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PXN—lung cancer	0.000966	0.00165	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—AVP—lung cancer	0.000957	0.00163	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—POMC—lung cancer	0.00095	0.00162	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—OXTR—lung cancer	0.000946	0.00161	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—AKR1C1—lung cancer	0.000946	0.00161	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—GRP—lung cancer	0.000946	0.00161	CbGpPWpGaD
Cetrorelix—Nausea—Docetaxel—lung cancer	0.000939	0.00227	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—JUNB—lung cancer	0.000934	0.00159	CbGpPWpGaD
Cetrorelix—Hypotension—Doxorubicin—lung cancer	0.000922	0.00223	CcSEcCtD
Cetrorelix—LHCGR—Signaling by GPCR—PIK3CG—lung cancer	0.000906	0.00155	CbGpPWpGaD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	0.000906	0.00154	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—GNG11—lung cancer	0.000886	0.00151	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—PIK3CD—lung cancer	0.000877	0.0015	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR ligand binding—CXCL8—lung cancer	0.00087	0.00148	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—AVP—lung cancer	0.000869	0.00148	CbGpPWpGaD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	0.000867	0.00148	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—POMC—lung cancer	0.000863	0.00147	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—STK11—lung cancer	0.000848	0.00145	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—VEGFC—lung cancer	0.000843	0.00144	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—IL6R—lung cancer	0.000841	0.00143	CbGpPWpGaD
Cetrorelix—Hypersensitivity—Methotrexate—lung cancer	0.000839	0.00203	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—FOXO3—lung cancer	0.000818	0.0014	CbGpPWpGaD
Cetrorelix—Pruritus—Methotrexate—lung cancer	0.000806	0.00195	CcSEcCtD
Cetrorelix—LHCGR—Signaling by GPCR—MAP2K1—lung cancer	0.000802	0.00137	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—PIK3CD—lung cancer	0.000797	0.00136	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ADCY1—lung cancer	0.000797	0.00136	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PPP2R1B—lung cancer	0.000776	0.00132	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—SMARCA4—lung cancer	0.000776	0.00132	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—AVP—lung cancer	0.000767	0.00131	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—PIK3CB—lung cancer	0.000765	0.0013	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—HSPB1—lung cancer	0.000749	0.00128	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PTHLH—lung cancer	0.00074	0.00126	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—IGF1R—lung cancer	0.000738	0.00126	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—CXCL8—lung cancer	0.000735	0.00125	CbGpPWpGaD
Cetrorelix—Hypersensitivity—Doxorubicin—lung cancer	0.000727	0.00176	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—HES1—lung cancer	0.000725	0.00124	CbGpPWpGaD
Cetrorelix—Rash—Methotrexate—lung cancer	0.000718	0.00174	CcSEcCtD
Cetrorelix—Dermatitis—Methotrexate—lung cancer	0.000717	0.00173	CcSEcCtD
Cetrorelix—Headache—Methotrexate—lung cancer	0.000713	0.00172	CcSEcCtD
Cetrorelix—LHCGR—Signaling by GPCR—RAF1—lung cancer	0.000711	0.00121	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—IL2—lung cancer	0.000702	0.0012	CbGpPWpGaD
Cetrorelix—Pruritus—Doxorubicin—lung cancer	0.000698	0.00169	CcSEcCtD
Cetrorelix—GNRHR—Signaling Pathways—ANXA1—lung cancer	0.000696	0.00119	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—PIK3CB—lung cancer	0.000694	0.00118	CbGpPWpGaD
Cetrorelix—Nausea—Methotrexate—lung cancer	0.000676	0.00164	CcSEcCtD
Cetrorelix—GNRHR—Signaling Pathways—FLT1—lung cancer	0.000674	0.00115	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—PIK3CG—lung cancer	0.000668	0.00114	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—CXCL8—lung cancer	0.000667	0.00114	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—ERBB3—lung cancer	0.000663	0.00113	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—APP—lung cancer	0.00066	0.00113	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—NOTCH3—lung cancer	0.00066	0.00113	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—FGF9—lung cancer	0.000655	0.00112	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—IL2—lung cancer	0.000638	0.00109	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—POMC—lung cancer	0.000636	0.00108	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—TERT—lung cancer	0.000635	0.00108	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—JUNB—lung cancer	0.000625	0.00107	CbGpPWpGaD
Cetrorelix—Rash—Doxorubicin—lung cancer	0.000622	0.0015	CcSEcCtD
Cetrorelix—Dermatitis—Doxorubicin—lung cancer	0.000621	0.0015	CcSEcCtD
Cetrorelix—Headache—Doxorubicin—lung cancer	0.000618	0.00149	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—FGFR1—lung cancer	0.000617	0.00105	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—HIF1A—lung cancer	0.000608	0.00104	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—PIK3CG—lung cancer	0.000607	0.00103	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—PIK3CD—lung cancer	0.000587	0.001	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—APOA1—lung cancer	0.000586	0.001	CbGpPWpGaD
Cetrorelix—Nausea—Doxorubicin—lung cancer	0.000586	0.00142	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—KDR—lung cancer	0.000581	0.000991	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—POMC—lung cancer	0.000577	0.000985	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—STK11—lung cancer	0.000568	0.000968	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—IL6R—lung cancer	0.000563	0.000961	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—FOXO3—lung cancer	0.000548	0.000934	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—MAP2K1—lung cancer	0.000537	0.000915	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—KIT—lung cancer	0.000535	0.000913	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PIK3CG—lung cancer	0.000535	0.000913	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—APC—lung cancer	0.000535	0.000913	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—NRAS—lung cancer	0.000535	0.000913	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—PIK3CD—lung cancer	0.000533	0.000909	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—EGF—lung cancer	0.000529	0.000902	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—AVP—lung cancer	0.000513	0.000875	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—MAPK3—lung cancer	0.000513	0.000874	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—PIK3CB—lung cancer	0.000512	0.000873	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—POMC—lung cancer	0.00051	0.000869	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—BRAF—lung cancer	0.000503	0.000858	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—IL6R—lung cancer	0.000497	0.000848	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CREBBP—lung cancer	0.000496	0.000846	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—IGF1R—lung cancer	0.000494	0.000843	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—CXCL8—lung cancer	0.000492	0.000839	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—EGFR—lung cancer	0.000488	0.000832	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—HES1—lung cancer	0.000485	0.000828	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—RAF1—lung cancer	0.000476	0.000812	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MAP2K1—lung cancer	0.000474	0.000808	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PIK3CD—lung cancer	0.000471	0.000803	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—IL2—lung cancer	0.00047	0.000802	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—PIK3CA—lung cancer	0.000466	0.000795	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—PIK3CB—lung cancer	0.000465	0.000793	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—KRAS—lung cancer	0.000461	0.000786	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—CXCL8—lung cancer	0.000447	0.000762	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ERBB3—lung cancer	0.000444	0.000757	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—IL2—lung cancer	0.000427	0.000728	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—TERT—lung cancer	0.000425	0.000725	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—PIK3CA—lung cancer	0.000423	0.000722	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MDM2—lung cancer	0.000422	0.000719	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—RAF1—lung cancer	0.00042	0.000716	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—ERBB2—lung cancer	0.000416	0.000709	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—FGFR1—lung cancer	0.000413	0.000704	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PIK3CB—lung cancer	0.00041	0.000699	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MTOR—lung cancer	0.00041	0.000699	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—HIF1A—lung cancer	0.000407	0.000694	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CXCL8—lung cancer	0.000394	0.000672	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—APOA1—lung cancer	0.000392	0.000669	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—HRAS—lung cancer	0.000392	0.000668	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—KDR—lung cancer	0.000389	0.000663	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—AKT1—lung cancer	0.000381	0.000649	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CASP3—lung cancer	0.000377	0.000643	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—IL2—lung cancer	0.000377	0.000642	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—IL6—lung cancer	0.000375	0.000639	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CCND1—lung cancer	0.000367	0.000626	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—JUN—lung cancer	0.000366	0.000625	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—APC—lung cancer	0.000358	0.000611	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PIK3CG—lung cancer	0.000358	0.000611	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—KIT—lung cancer	0.000358	0.000611	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—NRAS—lung cancer	0.000358	0.000611	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MMP9—lung cancer	0.000356	0.000608	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CDKN1A—lung cancer	0.000355	0.000606	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PTEN—lung cancer	0.000354	0.000604	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—EGF—lung cancer	0.000354	0.000604	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—AKT1—lung cancer	0.000346	0.00059	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—MAPK3—lung cancer	0.000343	0.000585	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—POMC—lung cancer	0.000341	0.000582	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—EP300—lung cancer	0.000338	0.000576	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—BRAF—lung cancer	0.000337	0.000574	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—IL6R—lung cancer	0.000333	0.000567	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CREBBP—lung cancer	0.000332	0.000567	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—SRC—lung cancer	0.000329	0.000561	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—EGFR—lung cancer	0.000326	0.000557	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—VEGFA—lung cancer	0.00032	0.000546	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MAP2K1—lung cancer	0.000317	0.000541	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—STAT3—lung cancer	0.000317	0.000541	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—NRAS—lung cancer	0.000316	0.000539	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PIK3CD—lung cancer	0.000315	0.000537	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—PIK3CA—lung cancer	0.000312	0.000532	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—KRAS—lung cancer	0.000308	0.000526	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MAPK3—lung cancer	0.000303	0.000516	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MYC—lung cancer	0.000295	0.000502	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—EGFR—lung cancer	0.000288	0.000491	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—PIK3CA—lung cancer	0.000283	0.000483	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MDM2—lung cancer	0.000282	0.000481	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—RAF1—lung cancer	0.000281	0.00048	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ERBB2—lung cancer	0.000278	0.000475	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MTOR—lung cancer	0.000275	0.000468	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PIK3CB—lung cancer	0.000275	0.000468	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—KRAS—lung cancer	0.000272	0.000464	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CXCL8—lung cancer	0.000264	0.00045	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—HRAS—lung cancer	0.000262	0.000447	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—AKT1—lung cancer	0.000255	0.000435	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CASP3—lung cancer	0.000253	0.000431	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—IL2—lung cancer	0.000252	0.00043	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—IL6—lung cancer	0.000251	0.000428	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PIK3CA—lung cancer	0.00025	0.000426	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CCND1—lung cancer	0.000246	0.000419	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—JUN—lung cancer	0.000245	0.000418	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—TP53—lung cancer	0.000242	0.000413	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MMP9—lung cancer	0.000239	0.000407	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CDKN1A—lung cancer	0.000238	0.000406	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PTEN—lung cancer	0.000237	0.000405	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—AKT1—lung cancer	0.000231	0.000395	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—HRAS—lung cancer	0.000231	0.000395	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—EP300—lung cancer	0.000226	0.000386	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—IL6—lung cancer	0.000221	0.000378	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—SRC—lung cancer	0.00022	0.000375	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—VEGFA—lung cancer	0.000214	0.000365	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—STAT3—lung cancer	0.000212	0.000362	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—NRAS—lung cancer	0.000212	0.000361	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—AKT1—lung cancer	0.000204	0.000348	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MAPK3—lung cancer	0.000203	0.000346	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MYC—lung cancer	0.000197	0.000336	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—EGFR—lung cancer	0.000193	0.000329	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—KRAS—lung cancer	0.000182	0.000311	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PIK3CA—lung cancer	0.000167	0.000285	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—TP53—lung cancer	0.000162	0.000276	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—HRAS—lung cancer	0.000155	0.000264	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—IL6—lung cancer	0.000148	0.000253	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—AKT1—lung cancer	0.000137	0.000233	CbGpPWpGaD
